Users Coming Off Slimming Injections Gain Back Weight Four Times Faster Compared to Dieters

A recent study indicates that people who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise regimens.

Research printed in a leading health publication demonstrates that while obese people frequently drop a large proportion of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month after stopping.

"Individuals buying these drugs must be aware of the potential of fast rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.

That rate of recovery means a return to original mass in about 18 months.

Weighing Therapies

The research, which looked at dozens of studies involving over 9,000 of participants, compared the effects of the injectable medications with other pills.

The team note that individuals who lose weight through lifestyle changes alone typically see a more gradual weight regain—approximately 100 grams monthly—once they finish.

Understanding the Rapid Regain

Doctors suggest the mechanism of the jabs is key to understanding the amplified weight return.

The injections mimic a natural hormone called GLP-1, which helps regulate appetite.

"Artificially providing the hormone concentrations far above than normal could lead to the body to produce less of its own natural hormone, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating far more likely."

An Ongoing Disease?

The NHS advise the injections for people with weight-linked medical conditions, alongside recommended lifestyle changes.

A number of clinicians contend that, due to the likelihood of relapse, the therapy is often ongoing.

This perspective is supported by pharmaceutical companies, who state that the results "emphasize the chronic character of excess weight," akin to managing conditions like diabetes.

Patient Experiences

Individuals who have discontinued the medication describe a intense return of hunger.

"I experienced a trigger activating and you become starving," recalled one woman.

This difficulty is exacerbated if patients have not established lasting lifestyle or habit changes during therapy.

Growing Interest

Survey data indicate that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.

• Adoption is higher among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion access the medications through private healthcare rather than the NHS.

Ultimately, researchers caution that while these medications are potent tools for weight loss, they are not a standalone solution and lasting health benefits hinges on ongoing lifestyle changes.